165 related articles for article (PubMed ID: 33680287)
1. VDAC1 Conversely Correlates with Cytc Expression and Predicts Poor Prognosis in Human Breast Cancer Patients.
Chen F; Yin S; Luo B; Wu X; Yan H; Yan D; Chen C; Guan F; Yuan J
Oxid Med Cell Longev; 2021; 2021():7647139. PubMed ID: 33680287
[TBL] [Abstract][Full Text] [Related]
2. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
[TBL] [Abstract][Full Text] [Related]
3. miRNA-874-3p inhibits the migration, invasion and proliferation of breast cancer cells by targeting VDAC1.
Yang H; Wang Z; Hu S; Chen L; Li W; Yang Z
Aging (Albany NY); 2023 Jan; 15(3):705-717. PubMed ID: 36750173
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
5. Lidocaine promotes apoptosis in breast cancer cells by affecting VDAC1 expression.
Long D; Fang X; Yuan P; Cheng L; Li H; Qu L
BMC Anesthesiol; 2022 Aug; 22(1):273. PubMed ID: 36042412
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication of voltage-dependent anion channel 1 in uterine cervical cancer and its action on cervical cancer cells.
Wu CH; Lin YW; Wu TF; Ko JL; Wang PH
Oncotarget; 2016 Jan; 7(4):4210-25. PubMed ID: 26716410
[TBL] [Abstract][Full Text] [Related]
7. DYNLT1 promotes mitochondrial metabolism to fuel breast cancer development by inhibiting ubiquitination degradation of VDAC1.
Huang L; Wei B; Zhao Y; Gong X; Chen L
Mol Med; 2023 Jun; 29(1):72. PubMed ID: 37280526
[TBL] [Abstract][Full Text] [Related]
8. Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes.
Wang H; Yao J; Zhu Y; Zhan W; Chen X; Shen K
Cancer Med; 2020 Sep; 9(17):6173-6185. PubMed ID: 32657039
[TBL] [Abstract][Full Text] [Related]
9. miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN.
Xiao S; Zhu H; Luo J; Wu Z; Xie M
Oncol Rep; 2019 Dec; 42(6):2550-2560. PubMed ID: 31638259
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?
Sheridan W; Scott T; Caroline S; Yvonne Z; Vanessa B; David V; Karen G; Stephen C
Breast Cancer Res Treat; 2014 Oct; 147(3):617-29. PubMed ID: 25209005
[TBL] [Abstract][Full Text] [Related]
11. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
Sheng J; Xue X; Jiang K
Curr Mol Med; 2019; 19(2):147-155. PubMed ID: 30854965
[TBL] [Abstract][Full Text] [Related]
13. Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis.
Imamura T; Yamamoto-Ibusuki M; Sueta A; Kubo T; Irie A; Kikuchi K; Kariu T; Iwase H
Breast Cancer; 2016 Nov; 23(6):876-885. PubMed ID: 26494574
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of mitochondrial voltage-dependent anion channel-1 associated genes predicts recurrence-free survival in human carcinomas.
Ko JH; Gu W; Lim I; Zhou T; Bang H
PLoS One; 2014; 9(10):e110094. PubMed ID: 25333947
[TBL] [Abstract][Full Text] [Related]
15. Clinical implication of leucine zipper/EF hand-containing transmembrane-1 overexpression in the prognosis of triple-negative breast cancer.
Wang CA; Liu Q; Chen Y; Liu S; Xu J; Cui X; Zhang Y; Piao L
Exp Mol Pathol; 2015 Apr; 98(2):254-9. PubMed ID: 25617527
[TBL] [Abstract][Full Text] [Related]
16. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
[TBL] [Abstract][Full Text] [Related]
17. Expression of LPA2 is associated with poor prognosis in human breast cancer and regulates HIF-1α expression and breast cancer cell growth.
Li M; Xiao D; Zhang J; Qu H; Yang Y; Yan Y; Liu X; Wang J; Liu L; Wang J; Duan X
Oncol Rep; 2016 Dec; 36(6):3479-3487. PubMed ID: 27805252
[TBL] [Abstract][Full Text] [Related]
18.
Uzelac B; Krivokuca A; Susnjar S; Milovanovic Z; Supic G
Genet Test Mol Biomarkers; 2021 Mar; 25(3):227-235. PubMed ID: 33734898
[No Abstract] [Full Text] [Related]
19. Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer.
Choi JS; Kim KH; Oh E; Shin YK; Seo J; Kim SH; Park S; Choi YL
Pathology; 2017 Oct; 49(6):618-626. PubMed ID: 28818465
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
